Here are the S-3 shelf registrations from Biodesix, Inc. (BDSX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow BDSX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BDSX filings page.
Biodesix, Inc. is registering up to 375,000 shares of common stock for resale by Perceptive Credit Holdings IV, LP. This prospectus registers resale rights for shares issuable upon exercise of warrant certificates granted under multiple amendments to a credit agreement. The Company will not receive proceeds from resale; any cash exercise proceeds would be received by the Company. The filing discloses a Beneficial Ownership Limitation that prevents Perceptive from exercising warrants if post-exercise ownership would exceed 9.99%. The prospectus lists 10,355,809 shares outstanding as of May 20, 2026 and states the Nasdaq last sale price was $14.37 on May 20, 2026.